Pages that link to "Q84048428"
Jump to navigation
Jump to search
The following pages link to Window of opportunity for daclizumab (Q84048428):
Displaying 7 items.
- Role of the immunogenic and tolerogenic subsets of dendritic cells in multiple sclerosis (Q28082878) (← links)
- Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum. (Q34377832) (← links)
- CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients (Q35588533) (← links)
- Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity (Q36014986) (← links)
- Multi-cellular natural killer (NK) cell clusters enhance NK cell activation through localizing IL-2 within the cluster (Q37578835) (← links)
- Modulation of IL-2Rα with daclizumab for treatment of multiple sclerosis. (Q38111620) (← links)
- Daclizumab: Development, Clinical Trials, and Practical Aspects of Use in Multiple Sclerosis (Q39434495) (← links)